Ann: Notice of Extraordinary General Meeting/Proxy Form, page-7

"An Australian company has achieved a major breakthrough in the treatment of the common heart condition aortic stenosis, using bovine tissue to develop a device that can avoid open heart surgery.
The single-piece valve device, pioneered by Brisbane company Anteris Technologies, has been more than three years in the making and is seen by cardiologists as a potential game-changer in the treatment of aortic valves."


Article from The Australian

"But despite the prevalence of the TAVI treatment, the strength and longevity of valve devices remains a mixed picture, according to leading cardiologist Karl Poon.
“TAVI has come a long way and it’s more than likely it will become the dominant cardiac strategy going forward,” he said. “But the key issue with these devices is their durability.
“Patients are having to undergo the procedure sometimes up to three times, so we really need a device that will last as long as possible which makes Anteris’s new valve, DurAVR, truly revolutionary.”